Answer:
a. 7.48%
Explanation:
Number of shares = $ 6,000 / $ 38.10
Number of shares = 157.48
Rate of return = [Number of shares * (Short term gans + Long term gains + ((1 - Front end load) * (Current offering price)) - Purchase price] / Purchase price
Rate of return = [157.48 * ($0.20 + $1.04 + ((1 - 0.05 ) * $41.80)) - $6,000] / $6,000
Rate of return = [157.48 * ($0.20 + $1.04 + (0.95 * $41.80)) - $6,000] / $6,000
Rate of return = [157.48 * ($1.24 + $39.71) - $6,000] / $6,000
Rate of return = $448.806 / $6,000
Rate of return = 0.074801
Rate of return = 7.48%
Duration of the project. from start to end
Answer:
$30.07
Explanation:
Rocky river company uses target pricing
The production volume is 602,000 units
The market price is $34 per unit
The total assets is $13,900,000
The desired operating income is 17% of the total assets
= 17/100 × 13,900,000
= 0.17×13,900,000
= 2,363,000
The first step is to calculate the sales value
= 602,000 ×34
= 20,468,000
The total cost can be calculated as follows
= Sales value-desired operating income
= 20,468,000-2,363,000
= 18,105,000
Therefore the target full product cost per unit can be calculated as follows
= Total cost/production volume
= 18,105,000/602,000
= $30.07
Hence the full target product cost per unit is $30.07
Answer:
Permanent accounts
Explanation:
The post-closing trial balance consists only of permanent accounts. These permanent accounts are assets, liabilities, and equity. Permanent accounts are not closed when an accounting period ends. Temporary accounts (revenue, expense, dividend) on the other hand is a direct opposite as they are closed or cleared to zero when an accounting period ends.
<span>If the changes need to be done immediately in order to benefit the health of the client, then IRB approval is not required. The IRB, which stands for Institutional Review Board, is a select group of people that review and regulate biomedical research in which human beings are involved. This group is regulated by the FDA.</span>